Dendritic cells as carriers for a cytotoxic T-lymphocyte epitope–based peptide vaccine in protection against a human papillomavirus type 16–induced tumor

MA Ossevoort, MCW Feltkamp… - Journal of …, 1995 - journals.lww.com
Previously we have demonstrated that two doses of a cytotoxic T lymphocyte (CTL) epitope–
based peptide vaccine of human papillomavirus type 16 (HPV 16) E7 aa 49–57 elicit …
被引用次数：167 相关文章

[引用][C] Dendritic cells as carriers for a cytotoxic T-lymphocyte epitope-based peptide vaccine in protection against a human papillomavirus type 16-induced tumor

MA OSSEVOORT, MCW FELTKAMP… - … with emphasis on …, 1995 - pascal-francis.inist.fr
Dendritic cells as carriers for a cytotoxic T-lymphocyte epitope-based peptide vaccine in protection
against a human papillomavirus type 16-induced tumor CNRS Inist Pascal-Francis CNRS Pascal …

[引用][C] Dendritic Cells as Carriers for a Cytotoxic T-Lymphocyte Epitope-Based Peptide Vaccine in Protection Against a Human Papillomavirus Type 16-Induced Tumor

MA Ossevoort, MCW Feltkamp, KJH van Veen… - Journal of …, 1995 - cir.nii.ac.jp
Dendritic Cells as Carriers for a Cytotoxic T-Lymphocyte Epitope-Based Peptide Vaccine in
Protection Against a Human Papillomavirus Type 16-Induced Tumor | CiNii Research CiNii …

Dendritic cells as carriers for a cytotoxic T-lymphocyte epitope-based peptide vaccine in protection against a human papillomavirus type 16-induced tumor.

MA Ossevoort, MC Feltkamp, KJ van Veen… - … with Emphasis on …, 1995 - europepmc.org
Previously we have demonstrated that two doses of a cytotoxic T lymphocyte (CTL) epitope-
based peptide vaccine of human papillomavirus type 16 (HPV 16) E7 aa 49-57 elicit …

Dendritic cells as carriers for a cytotoxic T-lymphocyte epitope-based peptide vaccine in protection against a human papillomavirus type 16-induced tumor

MA Ossevoort, MC Feltkamp… - … with emphasis on …, 1995 - pubmed.ncbi.nlm.nih.gov
Previously we have demonstrated that two doses of a cytotoxic T lymphocyte (CTL) epitope-
based peptide vaccine of human papillomavirus type 16 (HPV 16) E7 aa 49-57 elicit …
[PDF] academia.edu

[PDF][PDF] Dendritic Cells as Carriers for a Cytotoxic T-Lymphocyte Epitope-Based Peptide Vaccine in Protection Against a Human Papillomavirus Type 16–Induced …

MA Ossevoort, MCW Feltkamp, KJH van Veen - academia.edu
Previously we have demonstrated that two doses of a cytotoxic T lymphocyte (CTL) epitope-
based peptide vaccine of human papillomavirus type 16 (HPV 16) E7 aa 49–57 elicit …

[引用][C] Dendritic cells as carriers for a cytotoxic T-lymphocyte epitope-based peptide vaccine in protection against a human papillomavirus type 16-induced tumor

M Ossevoort, M Feltkamp, K van Veen… - … : with emphasis on …, 1995 - research.rug.nl
Dendritic cells as carriers for a cytotoxic T-lymphocyte epitope-based peptide vaccine in
protection against a human papillomavirus type 16-induced tumor — the University of …
[PDF] academia.edu

[PDF][PDF] Dendritic Cells as Carriers for a Cytotoxic T-Lymphocyte Epitope-Based Peptide Vaccine in Protection Against a Human Papillomavirus Type 16–Induced …

MA Ossevoort, MCW Feltkamp, KJH van Veen - academia.edu
Previously we have demonstrated that two doses of a cytotoxic T lymphocyte (CTL) epitope-
based peptide vaccine of human papillomavirus type 16 (HPV 16) E7 aa 49–57 elicit …

[引用][C] Dendritic cells as carriers for a cytotoxic T-lymphocyte epitope-based peptide vaccine in protection against a human papillomavirus type 16-induced tumor

MA OSSEVOORT, MCW FELTKAMP… - … of immunotherapy with …, 1995 - Raven Press